Leukemia & Cell Therapy/Transplant faculty @CUHematology | Physician-scientist | Previously @PennCancer @PennIMResidents @UMNMSTP @DukeU
Joined February 2018
- Tweets 16
- Following 181
- Followers 123
- Likes 46
1 Photos and videos
Apr 21
Pleased to share our manuscript featured on the cover of @BloodPortfolio on CD2-targeting CART and CD2 signaling in CART. Great to work with @AlbertoCarturan @MarcoRuella and all to share this story - expanding targets for aggressive T cell neoplasms.
sciencedirect.com/science/ar…
New issue of Blood out now featuring Anti-CD2 CAR T-cells for T-cell neoplasms, Inflammatory landscape in clonal hematopoiesis, GRK5 variant linked to thrombotic disease, and more. Explore here: ashpublications.org/blood/is…
1
1
4
436
8 Feb 2025
Pleased to share our results in @NatureMedicine using CAR-macrophages against solid tumors in this FIH trial. CAR-M were safe and showed tumor immunomodulatory activity in heavily pretreated pts. Great to work with @KReissMD and all authors! @PennCancer
1
2
2
610
8 Feb 2025
1
3
288
Mat Angelos retweeted
8 Dec 2024
Grateful to #ASH2024 for the chance to present our work on overcoming the absence of CD2:CD58 co-stimulation using an innovative PD1:iCD2 switch receptor. Thanks to my mentor @MarcoRuella and the @RuellaLab for their invaluable support. Excited to delve deeper into this approach!
6
13
1,038
Mat Angelos retweeted
19 Jul 2024
Congrats to the now Dr. @_ruchipatel
for the publication of her PhD thesis in @SciImmunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models. @PennMedicine @RuellaLab science.org/doi/10.1126/scii…
5
28
120
9,264
3 Jun 2024
Congrats @PuneethGuru_ on leading this fantastic work. Looking forward to seeing this evolve into the clinic!
3 Jun 2024
The main work of my PhD, truly a multi-team/disciplinary story, is out today in @NatImmunol. We show that the BTLA-HVEM immune checkpoint is enriched in the tumor microenvironment and blunts CAR T cell function. High BTLA in patient CART19 → poor outcome. nature.com/articles/s41590-0…
3
465
Mat Angelos retweeted
12 Dec 2023
@Mat_Angelos from our @RuellaLab presenting for the for the first time a novem CD2 deleted CART2 for T-ALL: High preclinical efficacy against primary leukemias #ASH23 @PennMedicine
3
8
597
6 Dec 2023
Looking forward to speaking about our work on CD2-targeting CAR T at #ASH23. Please check it out Mon 315PM and to connect if interested! @MarcoRuella @_ruchipatel @PennCancer ash.confex.com/ash/2023/webp…
1
3
14
908
6 Dec 2023
Check out some other novel CART strategies from @RuellaLab being presented and led by the talented @_ruchipatel and @PuneethGuru_ ash.confex.com/ash/2023/webp…. ash.confex.com/ash/2023/webp…. ash.confex.com/ash/2023/webp…
3
3
551
3 Dec 2023
Check out some recent updates and our viewpoints for using CAR-T in T-cell leukemias/lymphomas. Great review to prep to #ASH23! @MarcoRuella @StefanBartaMD @_ruchipatel
sciencedirect.com/science/ar…
5
12
1,135
3 Jun 2022
Check out our phase 1 CAR-M study in progress at the Developmental Therapeutics session Sunday AM. Excited to meet you at 327b and discuss other new cell therapy work at #ASCO2022 @KReissMD
3 Jun 2022
🔬 Can macrophages be harnessed to #CARTherapy to fight solid tumors?
@KReissMD presents on a first-in-human study of the anti-HER2 CAR macrophage CT-0508 in patients with #HER2 overexpressing solid tumors: spr.ly/6017znKjJ
#ASCO22 #CARM
1
8
10 Mar 2022
Check out our recent (open-access!) review on what's new in treating T-cell lymphomas. mdpi.com/1494870
2
2 May 2018
Feel like there should be a greater emphasis on understanding when/how to implement appropriate statistical methods and improve study designs than just simply lowering the significance threshold...
The Proposal to Lower P Value Thresholds to .005 ja.ma/2HFzzye
22 Feb 2018
Great approach for grad student training at Hopkins. Programming and bioinformatics work was some of the most creative and formative parts of my research; would be great to see this emphasized in more biological science programs. x.com/nature/status/96651288…
22 Feb 2018
Many doctoral curricula aim to produce narrowly focused researchers rather than critical thinkers. That can and must change, says Gundula Bosch go.nature.com/2Ew4qb9
21 Feb 2018
Starting up my first Twitter page! Excited to use this as a platform to disseminate thought-provoking, evidence-based, and informative content. Hope to include a lot of science, medicine, medical education, STEM career development, and some other personal interests!
2